News.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 3, p. i, doi. 10.1086/655755
- By:
- Publication type:
- Article
Works matching DE "PROGENICS Pharmaceuticals Inc."
Results: 8
1
2
Positive interim Phase II results of PRO 140 for HIV treatment.
- Published in:
- Expert Review of Anti-infective Therapy, 2008, v. 6, n. 6, p. 783
- Publication type:
- Article
3
Methylnaltrexone: MNTX.
- Published in:
- Drugs in R&D, 2006, v. 7, n. 6, p. 374
- Publication type:
- Article
4
PRELIMINARY CLINICAL RESULTS FOR METHYLNALTREXONE ORAL AND INTRAVENOUS FORMULATIONS.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2008, v. 22, n. 3, p. 262
- Publication type:
- Article
5
METHYLNALTREXONE APPROVED IN CANADA AND THE UNITED STATES FOR OPIOID-INDUCED CONSTIPATION.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2008, v. 22, n. 3, p. 261
- Publication type:
- Article
6
METHYLNALTREXONE GAINS FDA FAST TRACK DESIGNATION FOR POSTOPERATIVE ILEUS.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2007, v. 21, n. 1, p. 114
- Publication type:
- Article
7
News in brief.
- Published in:
- Chemistry & Industry, 2006, n. 2, p. 4
- Publication type:
- Article
8
Entry inhibitors under development.
- Published in:
- Chemistry & Industry, 2003, n. 17, p. 6
- Publication type:
- Article